Cargando…

Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease

Phosphodiesterase-4 inhibitors (PDE4Is) are potent anti-inf lammatory agents and roflumilast has been used to prevent acute exacerbation of chronic obstructive pulmonary disease (COPD). Roflumilast decreases neutrophil migration, restores cystic fibrosis transmembrane conductance regulator activity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhee, Chin Kook, Kim, Deog Kyeom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061018/ https://www.ncbi.nlm.nih.gov/pubmed/32131571 http://dx.doi.org/10.3904/kjim.2020.035

Ejemplares similares

Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome
por: Rhee, Chin Kook
Publicado: (2015)

Role of Nuclear Factor Erythroid 2‒Related Factor 2 in Chronic Obstructive Pulmonary Disease
por: Ban, Woo Ho, et al.
Publicado: (2022)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease
por: Kim, Sei Won, et al.
Publicado: (2017)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease
por: Choi, Joon Young, et al.
Publicado: (2022)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry
por: Kim, Joo Kyung, et al.
Publicado: (2016)

What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure?
por: Kim, Deog Kyeom, et al.
Publicado: (2018)

The global status of chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2021)

Association Between Air Pollution and Viral Infection in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Juwhan, et al.
Publicado: (2023)

Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?
por: Goonathilake, Mastiyage R, et al.
Publicado: (2022)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015–2019
por: Kim, Sang Hyuk, et al.
Publicado: (2023)

Epidemiology, burden, and policy of chronic obstructive pulmonary disease in South Korea: a narrative review
por: Lee, Eung Gu, et al.
Publicado: (2021)

The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients
por: Jo, Yong Suk, et al.
Publicado: (2018)

Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD)
por: Choi, Joon Young, et al.
Publicado: (2020)

Short-term Evaluation of a Comprehensive Education Program Including Inhaler Training and Disease Management on Chronic Obstructive Pulmonary Disease
por: Yoo, Kwang Ha, et al.
Publicado: (2017)

Clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease
por: Jung, Young Ho, et al.
Publicado: (2015)

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
por: Butrous, Ghazwan
Publicado: (2014)

Validation of the Rome proposal for severity of acute exacerbation of chronic obstructive pulmonary disease
por: Lee, Hyo Jin, et al.
Publicado: (2023)

Chronic cough as a novel phenotype of chronic obstructive pulmonary disease
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2018)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort
por: Lee, Jung Yeon, et al.
Publicado: (2016)

The clinical efficacy of AG NPP709 (Synatura(®)) in patients with chronic bronchitis type stable chronic obstructive pulmonary disease
por: Lee, Eung Gu, et al.
Publicado: (2020)

The effect of obesity on patients with mild chronic obstructive pulmonary disease: results from KNHANES 2010 to 2012
por: Park, Ju-Hee, et al.
Publicado: (2017)

Decline in Carbon Monoxide Transfer Coefficient in Chronic Obstructive Pulmonary Disease
por: Kim, Yeon Wook, et al.
Publicado: (2020)

Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
por: Kim, Kyung Hoon, et al.
Publicado: (2017)

Nationwide quality assessment of treatment for chronic obstructive pulmonary disease
por: Kim, Kyu Yean, et al.
Publicado: (2020)

Summary of the Chronic Obstructive Pulmonary Disease Clinical Practice Guideline Revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease
por: Yoon, Hyoung Kyu, et al.
Publicado: (2017)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

The Effectiveness and Harms of Screening for Chronic Obstructive Pulmonary Disease: An Updated Systematic Review and Meta-Analysis
por: Choi, Nahye, et al.
Publicado: (2022)

Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19
por: Kim, Youlim, et al.
Publicado: (2022)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations
por: Yoon, Sunyoung, et al.
Publicado: (2019)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease
por: Joo, Hyonsoo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csqf2age2v66jsc0mb7bav3jra